MEDIAN TECHNOLOGIES (ALMDT.PA) Stock Fundamental Analysis
Europe - EPA:ALMDT - FR0011049824 - Common Stock
2.9 EUR
-0.12 (-3.97%)
We assign a fundamental rating of 2 out of 10 to ALMDT. ALMDT was compared to 10 industry peers in the Health Care Technology industry. ALMDT has a bad profitability rating. Also its financial health evaluation is rather negative. ALMDT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ALMDT had negative earnings in the past year.
ALMDT had a negative operating cash flow in the past year.
In the past 5 years ALMDT always reported negative net income.
ALMDT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ALMDT has a Return On Assets of -103.56%. This is amonst the worse of the industry: ALMDT underperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -103.56% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 103.86%, ALMDT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ALMDT's Gross Margin has been stable in the last couple of years.
ALMDT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 103.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
2. Health
2.1 Basic Checks
ALMDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALMDT has more shares outstanding than it did 1 year ago.
ALMDT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALMDT has a worse debt to assets ratio.
2.2 Solvency
ALMDT has an Altman-Z score of -9.82. This is a bad value and indicates that ALMDT is not financially healthy and even has some risk of bankruptcy.
ALMDT's Altman-Z score of -9.82 is on the low side compared to the rest of the industry. ALMDT is outperformed by 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9.82 |
ROIC/WACCN/A
WACC10.92%
2.3 Liquidity
ALMDT has a Current Ratio of 0.47. This is a bad value and indicates that ALMDT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.47, ALMDT is doing worse than 90.00% of the companies in the same industry.
A Quick Ratio of 0.46 indicates that ALMDT may have some problems paying its short term obligations.
ALMDT has a Quick ratio of 0.46. This is amonst the worse of the industry: ALMDT underperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.46 |
3. Growth
3.1 Past
ALMDT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.88%.
The Revenue has been growing slightly by 3.25% in the past year.
Measured over the past years, ALMDT shows a very strong growth in Revenue. The Revenue has been growing by 20.72% on average per year.
EPS 1Y (TTM)-8.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.92%
Revenue 1Y (TTM)3.25%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%10.21%
3.2 Future
The Earnings Per Share is expected to grow by 26.15% on average over the next years. This is a very strong growth
ALMDT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.27% yearly.
EPS Next Y70.11%
EPS Next 2Y37.3%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue Next Year3.31%
Revenue Next 2Y11.58%
Revenue Next 3Y21.27%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALMDT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMDT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALMDT's earnings are expected to grow with 26.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.3%
EPS Next 3Y26.15%
5. Dividend
5.1 Amount
ALMDT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALMDT (11/3/2025, 7:00:00 PM)
2.9
-0.12 (-3.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners9.7%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap101.27M
Revenue(TTM)22.95M
Net Income(TTM)-25240000
Analysts86
Price Target8.81 (203.79%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.23%
PT rev (3m)-48.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)61.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.41 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.66
BVpS-0.97
TBVpS-1.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -103.56% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 103.86% | ||
| FCFM | N/A |
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
F-Score3
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 53.59% | ||
| Cap/Sales | 4.71% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.46 | ||
| Altman-Z | -9.82 |
F-Score3
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)102.16%
Cap/Depr(5y)84.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.92%
EPS Next Y70.11%
EPS Next 2Y37.3%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue 1Y (TTM)3.25%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%10.21%
Revenue Next Year3.31%
Revenue Next 2Y11.58%
Revenue Next 3Y21.27%
Revenue Next 5YN/A
EBIT growth 1Y2.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.92%
EBIT Next 3Y29.67%
EBIT Next 5YN/A
FCF growth 1Y11.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.31%
OCF growth 3YN/A
OCF growth 5YN/A
MEDIAN TECHNOLOGIES / ALMDT.PA FAQ
What is the ChartMill fundamental rating of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA.
What is the valuation status of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?
ChartMill assigns a valuation rating of 1 / 10 to MEDIAN TECHNOLOGIES (ALMDT.PA). This can be considered as Overvalued.
What is the profitability of ALMDT stock?
MEDIAN TECHNOLOGIES (ALMDT.PA) has a profitability rating of 1 / 10.
What is the earnings growth outlook for MEDIAN TECHNOLOGIES?
The Earnings per Share (EPS) of MEDIAN TECHNOLOGIES (ALMDT.PA) is expected to grow by 70.11% in the next year.
How sustainable is the dividend of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?
The dividend rating of MEDIAN TECHNOLOGIES (ALMDT.PA) is 0 / 10 and the dividend payout ratio is 0%.